Global Variations in Blood Collection: What Explains the Differences?
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, has shared a post on LinkedIn:
”Blood Donation: Why do collection volumes vary by country?
You might think that donating blood is the same experience everywhere.
However, the volume collected depends… on the country! And that’s no coincidence.
In France, the standard volume is 475mL per donation. This is very close to what’s practiced in Germany, Canada, or the United States, where 500mL is collected. Why? Because the average body size is larger, and recommendations are adapted to donors’ physiology.
It’s important to know that the volume collected never exceeds 13% of donor’s total blood volume. Additionally, standard volumes are always given with a margin of about ±10% to account for individual variations.
Conversely, in several Asian countries, the volume is reduced. In Vietnam, for example, a standard donation is 𝟯𝟱𝟬 𝗺𝗟. In China, donors can even choose: 200, 300, or 400 mL. These smaller volumes take into account average body weight, hemoglobin levels, and local medical standards.
These differences reflect not only morphological realities but also cultural and regulatory approaches to public health. Some countries favor more frequent donations but in smaller amounts, while others focus on larger volumes spaced further apart.
The same gesture, different contexts.
What remains universal is the importance of donation: whether 200 or 500 mL, every contribution saves lives.
And while the volume may change, the human value of the gesture remains constant.”
Stay updated on the emerging in transfusion medicine with Hemostasis Today.
-
Oct 13, 2025, 03:53Ganesh Mohan is Organising a Webinar to Improve Awareness About Thrombophilia on World Thrombosis Day
-
Oct 13, 2025, 02:47Thomas Reiser: Don't Miss This ISTH Research Recap with Robert Sidonio, Cedric Hermans and Michael Makris
-
Oct 12, 2025, 15:39Renjith Vijayakumar Selvarani: A Heart Attack Isn’t Just a Health Scare — It’s a Medical Emergency
-
Oct 12, 2025, 11:28Is it time for GLP1 receptor agonists in VTE care?
-
Oct 12, 2025, 11:26WFH: Women and Girls with Bleeding Disorders
-
Oct 13, 2025, 03:32Wolfgang Miesbach: This Study from Children's Hospital of Philadelphia Provides Crucial Insights Into Elevidys
-
Oct 13, 2025, 02:43Lukas Meyer and Colleagues on Reperfusion-dependent Treatment Effects of Thrombectomy in Large Ischemic Infarcts
-
Oct 12, 2025, 10:14Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines
-
Oct 12, 2025, 07:28Roberta Gualtierotti: rFVIIIFc and rFIXFc Ensured Effective Haemostasis and Favourable Safety in Major Orthopaedic Surgery
-
Oct 12, 2025, 01:32Evaluating Drug–Drug Interactions in Cancer Patients Receiving Anticoagulants and Antineoplastics
-
Oct 13, 2025, 02:46Flora Peyvandi: First Proposed Blood Test for Chronic Fatigue Syndrome - What Scientists Think
-
Oct 13, 2025, 02:44Silvio Maresca: Honored to be part of this international research project - ThrombUS+
-
Oct 10, 2025, 12:25Robert Lewis: T Cells Are Wonderful - But They Can't Do Everything
-
Oct 9, 2025, 13:03Peter Graves: When the Bleeding Does Not Stop
-
Oct 8, 2025, 12:44Bobur Kholikov: Thrombosis Diagnostics with YHLO
-
Oct 13, 2025, 03:44Jorge Monge: It Was An Honor to Take Part in the 3rd EBA Workshop on Rare Blood Provision
-
Oct 13, 2025, 03:15Arun V. J: They Chose Death Over A Blood Transfusion — And Here’s Why I Stopped Judging Them
-
Oct 13, 2025, 03:13Rahaf Ajaj: The Persistent Gender Gap in Nobel Prizes - A Call for Greater Inclusion
-
Oct 13, 2025, 02:50Emmanuel J Favaloro: Again Promoting World Thrombosis Day - October 13
-
Oct 12, 2025, 07:38Antonio Vega With Incredible Team Led by the Great Dr Majluf